FdaApplication

ANDA 215194

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSPECGX LLC
application_typeANDA
approval_date2023-08-21

Products (2)

ProductActive ingredientStrengthDosage form
MORPHINE SULFATEMORPHINE SULFATE15MGTABLET;ORAL
MORPHINE SULFATEMORPHINE SULFATE30MGTABLET;ORAL

2 products